Difelikefalin (MR-13A9; CR-845; MR-13A-9; trade name Korsuva) is a novel, peripherally specific, and potent kappa opioid receptor agonist approved in 2021 as an analgesic opiod peptide for the treatment of moderate-to-severe itching. Difelikefalin was approved for medical use in the United States in
August 2021.
纯度:≥98%
CAS:1024828-77-0